«

»

Medtronic GI revenue decreased by 16% in Q2

Medtronic's respiratory, gastrointestinal and renal revenue decreased 16 percent in the second quarter of fiscal year 2023, according to earnings results released on Nov. 22. 

Read the full post at Becker's ASC
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive